HIGH RISK BRUGADA SYNDROME UNMASKED BY RECURRENT MICTURITION SYNCOPE, AGGRAVATED BY BETA-BLOCKER THERAPY, WITH COEXISTING MITRAL VALVE PROLAPSE: A CASE REPORT
Global Journal for Research Analysis · 15.07.2026 · 40
DOI: 10.36106/gjra/7805498 ↗Kurz gefasst
Fallbericht in der Zeitschrift Global Journal for Research Analysis, online erschienen am 15.07.2026. Verfasst von Sai Rohan Nutalapati und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nutalapati, S. R., & Gaddam, V. S. S. V. (2026). HIGH RISK BRUGADA SYNDROME UNMASKED BY RECURRENT MICTURITION SYNCOPE, AGGRAVATED BY BETA-BLOCKER THERAPY, WITH COEXISTING MITRAL VALVE PROLAPSE: A CASE REPORT. Global Journal for Research Analysis, 40. https://doi.org/10.36106/gjra/7805498
Vancouver
Nutalapati SR, Gaddam VSSV. HIGH RISK BRUGADA SYNDROME UNMASKED BY RECURRENT MICTURITION SYNCOPE, AGGRAVATED BY BETA-BLOCKER THERAPY, WITH COEXISTING MITRAL VALVE PROLAPSE: A CASE REPORT. Global Journal for Research Analysis. 2026:40. doi:10.36106/gjra/7805498
BibTeX
@article{Nutalapati2026,
author = {Nutalapati, Sai Rohan and Gaddam, Venkata Sesha Sai Varun},
title = {HIGH RISK BRUGADA SYNDROME UNMASKED BY RECURRENT MICTURITION SYNCOPE, AGGRAVATED BY BETA-BLOCKER THERAPY, WITH COEXISTING MITRAL VALVE PROLAPSE: A CASE REPORT},
journal = {Global Journal for Research Analysis},
year = {2026},
pages = {40},
doi = {10.36106/gjra/7805498}
}
EUVIMED